SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

OpenAI pioneers large-language models like GPT and DALL·E, enabling advanced AI applications. Their research emphasizes both cutting-edge capability and responsible deployment strategies.

OpenAI PreStocks

The symbol $OPENAI CRYPTO, presented as "OpenAI PreStocks," is trending amidst widespread community discussion labeling it a scam and questioning its legitimacy due to its clear lack of affiliation with the actual OpenAI company.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

Recent listings on exchanges such as KuCoin Alpha and Bitget, coupled with developer efforts to stabilize the market and paid fees for upcoming Tier-1 listings, are fueling intense community discussion around JYAI CRYPTO's potential as the "next PEPE" in the AI memecoin sector.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amidst escalating speculation of a potential buyout from major tech players like SpaceX or Amazon, leveraging its uniquely valuable n53 spectrum and deepening Apple partnership. The community is eagerly anticipating key FCC decisions regarding spectrum use and the deployment of Globalstar's C-3 constellation, seen as critical catalysts, with investors widely believing the company is significantly undervalued for its foundational role in direct-to-device connectivity and emerging IoT solutions.

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. The company was founded by James W. McCollum in July 2013 and is headquartered in Solana Beach, CA.

LENZ Therapeutics Inc.

LENZ Therapeutics is generating significant conversation driven by the strong initial adoption of its VIZZ eye drop for presbyopia and the upcoming high-profile direct-to-consumer marketing campaign featuring Sarah Jessica Parker, fueling widespread community excitement over its vast market potential and notable short interest.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

Spruce Biosciences is seeing immense speculative interest and extreme volatility after its Breakthrough Therapy Designation for a rare disease treatment catalyzed a dramatic price surge, drawing high analyst price targets. Community discussion is rife with debate over a recent institutional private placement at a substantial discount, balancing optimism for accelerated approval against concerns of dilution and further price swings.

Berachain

Berachain (BERA) is attracting significant attention due to its innovative Proof-of-Liquidity consensus, rapid Total Value Locked (TVL) growth, and recent ecosystem expansions like the Bectra upgrade and new BTC-focused vaults. The community is sharply divided between those anticipating a major breakout, citing strong fundamentals and institutional interest, and skeptics wary of past performance and token distribution concerns.

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

ORIC Pharmaceuticals Inc

ORIC Pharmaceuticals is generating significant buzz following positive preliminary data from its ORIC-944 prostate cancer trial and a strategic investment and clinical partnership with Pfizer. This clinical momentum, coupled with high short interest, is fueling community speculation about a potential short squeeze and future growth.

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Framingham, MA.

KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals is trending following the FDA approval of EKTERLY, the first and only oral on-demand treatment for hereditary angioedema, generating community discussion around its strong initial sales, potential for significant market adoption, and a possible short squeeze driven by high institutional ownership and substantial short interest.

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

CME Group Inc - Ordinary Shares - Class A

CME Group Inc

CME Group is trending following strong financial results driven by record trading volumes, with community discussion highlighting its strategic expansion into prediction markets and crypto derivatives as a stable hedge against market uncertainty.

Progressive Corp. is an insurance holding company, which engages in the provision of personal and commercial auto insurance, residential property insurance, and other specialty property-casualty insurance and related services. It operates through the following segments: Personal Lines, Commercial Lines, and Property. The Personal Lines segment includes agency and direct businesses. The Commercial Lines segment writes primary liability and physical damage insurance for automobiles and trucks owned and operated predominately by small business in the auto, for-hire transportation, contractor, for-hire specialty, tow, and for-hire livery markets. The Property segment covers residential property insurance for homeowners, other property owners, and renters. The company was founded on March 10, 1937, and is headquartered in Mayfield Village, OH.

Progressive Corp.

Progressive Corp

Progressive (PGR) is drawing significant attention following strong recent earnings that showcased robust performance and a healthy combined ratio, though the stock has experienced a notable price pullback. The community is actively discussing if this dip, partially attributed to post-dividend adjustments and analyst re-ratings, presents a prime buying opportunity given the company's strong fundamentals and leading position in the insurance sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ATS (NYSE:ATS) Rating Increased to Strong-Buy at Wall Street Zen

Wall Street Zen raised ATS from a "buy" rating to a "strong-buy" rating in a research note on Saturday...

ATS (TSE:ATS) Given New C$48.00 Price Target at Scotiabank

Scotiabank upped their price target on shares of ATS from C$47.00 to C$48.00 and gave the company an "outperform" rating in a research note on Thursday...

ATS (ATS) Tops Q3 Earnings and Revenue Estimates

ATS (ATS) delivered earnings and revenue surprises of +12.10% and +5.10%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

4 Industrial Stocks to Buy on Steady Rebound in Manufacturing Activity 

ISM's PMI rebound points to a manufacturing recovery, putting ATS, NDSN, DCI and RBC in focus as industrial stocks to buy on rising demand.

ATS (TSE:ATS) Price Target Raised to C$48.00 at TD Securities

TD Securities boosted their target price on shares of ATS from C$46.00 to C$48.00 and gave the company a "buy" rating in a research note on Monday...

ATS Corporation (NYSE:ATS) Receives Consensus Rating of "Hold" from Brokerages

ATS Corporation (NYSE:ATS - Get Free Report) has been given a consensus recommendation of "Hold" by the five ratings firms that are covering the company, MarketBeat.com reports. One research analyst...

ATS to Host Third Quarter Earnings Call Wednesday February 4, 2026, at 8:30 a.m. Eastern

ATS Corporation (TSX: ATS) (NYSE: ATS) (ATS or the Company) will report its financial results for the third quarter ended December 28, 2025, before markets open on Wednesday February 04, 2026. At...

ATS (NYSE:ATS) Shares Down 7.9% - Here's Why

ATS (NYSE:ATS) Trading Down 7.9% - Time to Sell...

ATS CFO Ryan McLeod Resigns To Join CAE As CFO

(RTTNews) - CAE Inc. (CAE), a Canadian technology company, and ATS Corp. (ATS.TO, ATS), an automation and technology company, on Monday announced that Chief Financial Officer Ryan McLeod resigned...

ATS Announces CFO Resignation

ATS Corporation (TSX: ATS) (NYSE: ATS) (ATS or the Company) today announced that Ryan McLeod has resigned from his role of Chief Financial Officer (CFO) to pursue an opportunity in an unrelated...

ATS Corp. engages in planning, designing, building, commissioning, and servicing automated manufacturing and assembly systems. It offers custom automation, repeat automation, automation products, and value-added services, including pre-automation and after-sales services to life sciences, chemicals, consumer products, electronics, food, beverage, transportation, energy, and oil and gas market. The company was founded by Klaus D. Woerner in 1978 and is headquartered in Cambridge, Canada.

ATS Corporation.

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

ATS
ATS Automation Tooling Systems, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ATS News

ATSATS Automation Tooling Systems, Inc.